CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Co-Diagnostics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.67+0.01 (+1.83%)
Close on Oct 19, 2026
- Market cap
- $2.87M
- P/E (TTM)
- –
- Dividend yield
- –
Co-Diagnostics, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $418.21K | $770.05K | – | – | – | – | – | 67.2% | -45.7% |
| Grant [Member] | $204.28K | $3.15M | – | – | – | – | – | 32.8% | -93.5% |
| Product Revenue [Member] | – | $770.05K | $991.47K | $34.22M | – | – | – | – | – |
| Grant Revenue [Member] | – | $3.15M | $5.82M | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| United States | $581.55K | $3.52M | $6.48M | $24.67M | $52.19M | – | – | 93.4% | -83.5% |
| Non-US [Member] | $40.94K | $391.84K | – | – | – | – | – | 6.6% | -89.6% |
| Americas [Member] | – | – | – | – | $52.19M | $44.86M | $214.97K | – | – |
| Rest of World [Member] | – | $391.84K | $331.86K | $9.55M | $45.70M | $29.69M | – | – | – |
From the segment and revenue-disaggregation notes of Co-Diagnostics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.